Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
11.81B
Market cap11.81B
Price-Earnings ratio
21.98
Price-Earnings ratio21.98
Dividend yield
Dividend yield
Average volume
1.05M
Average volume1.05M
High today
$88.36
High today$88.36
Low today
$86.26
Low today$86.26
Open price
$87.86
Open price$87.86
Volume
232.50K
Volume232.50K
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

As of today, Globus Medical(GMED) shares are valued at $87.43. The company's market cap stands at 11.81B, with a P/E ratio of 21.98.

On 2026-03-23, Globus Medical(GMED) stock moved within a range of $86.26 to $88.36. With shares now at $87.43, the stock is trading +1.4% above its intraday low and -1.0% below the session's peak.

Trading activity shows a volume of 232.5K, compared to an average daily volume of 1.05M.

The stock's 52-week range extends from a low of $51.79 to a high of $101.40.

The stock's 52-week range extends from a low of $51.79 to a high of $101.40.

GMED News

Simply Wall St 2d
Is It Time To Reassess Globus Medical After Its Recent 17% One-Year Gain?

If you are wondering whether Globus Medical's current share price reflects its true worth, the key pieces of the valuation puzzle can help you frame that decisi...

Is It Time To Reassess Globus Medical After Its Recent 17% One-Year Gain?
Nasdaq 3d
Should You Continue to Hold Insulet Stock in Your Portfolio?

Insulet PODD is well-poised to grow in the upcoming quarters, owing to its strong momentum for the Omnipod 5 automated insulin delivery (“AID”) system for both...

Should You Continue to Hold Insulet Stock in Your Portfolio?
TipRanks 5d
Globus Medical assumed with an Overweight at Wells Fargo

Wells Fargo assumed coverage of Globus Medical (GMED) with an Overweight rating and $104 price target The firm is maintaining the current rating, price target a...

Analyst ratings

71%

of 17 ratings
Buy
70.6%
Hold
29.4%
Sell
0%

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.